Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NETILDEX versus Betabioptal after phacoemulsification cataract surgery
2006-003305-13Phase 4Completed
- Sponsor
- SIFI SpA
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of netilmicin + dexamethasone and betamethasone + chloramphenicol in Postoperative ocular inflammation (2 arms), sponsored by SIFI SpA. Primary endpoint: Anterior chamber inflammation (flare). Started Aug 2006; status: completed.
02
Drugs
netilmicin + dexamethasonebetamethasone + chloramphenicol
03
Conditions
Postoperative ocular inflammation
Beyond the preview
Go deeper on 2006-003305-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003305-13.